Earnings
Establishment Labs Missed Its Margin Forecast At 70.8% As Distributors Hit 60% Of Overseas Sales
The CFO blamed a heavier distributor mix against a planned 50%, and the CEO said the Middle East conflict is hurting orders.
Establishment Labs (ESTA) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
The CFO blamed a heavier distributor mix against a planned 50%, and the CEO said the Middle East conflict is hurting orders.
Earnings
The CEO said hospital approval cycles push most reconstruction revenue into late 2027, and an FDA decision is expected at the end of this year or early next.
SEC Filings
The breast-implant maker raised its 2026 revenue outlook to more than $274 million, though it still lost $10.7 million in the quarter.
SEC Filings
An 8-K shows the initial term now ends in 2031, with up to five one-year renewals and changes to payment, continuity and pricing terms.